EGF Theramed Health Corp.

As of March 31, 2026, EGF THERAMED HEALTH CORP. carries a market capitalization of 651,844.96, placing it among publicly traded companies globally. Its enterprise value stands at 823,156.84, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, EGF THERAMED HEALTH CORP. has 11.62M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, EGF THERAMED HEALTH CORP. maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -27.25, indicating conservative leverage, while an interest coverage ratio of -0.13 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -11,141.98, reflecting losses generated across the asset base.

Over the twelve months ended March 31, 2026, EGF THERAMED HEALTH CORP. recorded 595,169.27 in income tax expense. The company reported a pretax loss of -1.67M and -2.25M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 21, 2026, EGF THERAMED HEALTH CORP.'s stock has declined approximately 70.53% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.27.

Over the twelve months ended March 31, 2026, EGF THERAMED HEALTH CORP. generated - - in revenue and converted that into -2.25M in net income, yielding earnings per share of -0.20. EBITDA reached -205,773.43, while operating income came in at -132,873.85.

As of March 31, 2026, EGF THERAMED HEALTH CORP. holds 7,835.02 in cash and equivalents against 1.19M in total debt, resulting in a net debt position of 777,398.83. Total book value stands at -3.37M, with working capital of -4.39M providing operational flexibility.

EGF THERAMED HEALTH CORP. produced -70,559.01 in operating cash flow over the twelve months ended March 31, 2026.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -10.82: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -9.38, meaning EGF THERAMED HEALTH CORP. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

EGF THERAMED HEALTH CORP.'s most recent stock split took place on July 13, 2022 with a 20:1 split ratio.

As of March 31, 2026, EGF THERAMED HEALTH CORP. has an Altman Z-Score of -4,781.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.